Polyomavirus BK neutralizing activity in human immunoglobulin preparations. - Wikidata - wikimedia - TriplyDB

Polyomavirus BK neutralizing activity in human immunoglobulin preparations.

Polyomavirus BK neutralizing activity in human immunoglobulin preparations.

http://www.wikidata.org/entity/Q34786755

about

BK polyoma virus infection and renal disease in non-renal solid organ transplantation BK nephropathy in the native kidneys of patients with organ transplants: Clinical spectrum of BK infection Defunctioning polymorphism in the immunoglobulin G inhibitory receptor (FcγRIIB-T/T232) does not impact on kidney transplant or recipient survival.BK virus nephropathy in renal transplant recipients.BK polyomavirus reactivation after reduced-intensity double umbilical cord blood cell transplantation.Renal graft biopsy assists diagnosis and treatment of renal allograft dysfunction after kidney transplantation: a report of 106 cases Infectious complications in kidney-transplant recipients desensitized with rituximab and intravenous immunoglobulin.Antibodies to BK virus in children prior to allogeneic hematopoietic cell transplant Incidence and outcomes of BK virus allograft nephropathy among ABO- and HLA-incompatible kidney transplant recipients BK viremia precedes hemorrhagic cystitis in children undergoing allogeneic hematopoietic stem cell transplantation.BK Polyomavirus and the Transplanted Kidney: Immunopathology and Therapeutic Approaches.Clearance of BK Virus Nephropathy by Combination Antiviral Therapy With Intravenous Immunoglobulin The BK virus in renal transplant recipients-review of pathogenesis, diagnosis, and treatment.Management of polyomavirus-associated nephropathy in renal transplant recipients.The human polyomavirus BK (BKPyV): virological background and clinical implications.Commercially available immunoglobulins contain virus neutralizing antibodies against all major genotypes of polyomavirus BK.Combination of Leflunomide and Everolimus for treatment of BK virus nephropathy.BK Polyomavirus: Clinical Aspects, Immune Regulation, and Emerging Therapies.Successful renal retransplantation after graft loss from BK polyomavirus infection in a human immunodeficiency virus-positive patient.JC polyomavirus viremia and progressive multifocal leukoencephalopathy in human leukocyte antigen-sensitized kidney transplant recipients desensitized with intravenous immunoglobulin and rituximab.Renal association clinical practice guideline in post-operative care in the kidney transplant recipient Evaluating the impact of pre-transplant desensitization utilizing a plasmapheresis and low-dose intravenous immunoglobulin protocol on BK viremia in renal transplant recipients.Native kidney BK virus nephropathy associated with chronic lymphocytic leukaemia.Renal Association Clinical Practice Guideline on post-operative care of the kidney transplant recipient.

P2860

Q26764877-44225B5F-875F-41D1-BEB6-C173E0B7687D Q28070240-E7A75144-330F-4760-8ECD-EA32BA140999 Q34106643-1AFD774F-E992-4EBA-A315-904572C0B1D0 Q34509585-A0683C9D-811D-4538-897F-70700B791C46 Q35202366-6056C922-F540-4B02-89F5-6DE683B19F1E Q35644308-86761616-A6A3-4A6C-AAF1-A803280F6BE5 Q35664634-78BCC10D-0012-41BC-824A-652A50C86206 Q35889274-2EAC7B75-A6DF-4967-A10B-9C5437D8CA1B Q36126901-7EFE24CB-1B32-4D0A-AE6B-1CD4561F0940 Q37174366-1F664BFE-EE85-4F06-94B3-E0A7BCC80C7F Q37375153-DFCEB95C-B1AD-4815-8AF6-84D266C26119 Q37738744-A1264135-7670-4077-8958-1775DFD3E3E8 Q37821326-55ED4A08-1FF8-4A68-A482-C112B3C573D2 Q38003050-13ABFF7E-FCAB-48EC-8BE5-7B6F97543EEB Q38115582-9C521A1C-554E-4EEA-B991-85658C2637D6 Q38904012-35D6390A-FDF1-4783-8DCD-4DD5A24504F4 Q38936258-06CCF04D-1027-4563-9362-D56075814DCC Q39180715-0DA86716-E7AD-4F19-A4C1-647BFD04A850 Q40513496-7C1626D6-BC0C-4A97-80B9-9E64537567D3 Q40965913-F00A6AF4-7D54-49BD-9028-C5524C445CA3 Q42343473-EAC8C41D-B94A-4A50-87BA-949E1DAEFA74 Q43436078-309A60D6-D337-4EF4-B514-9CC169F03663 Q45359251-8455067C-837D-40AD-9F69-7A78D721421B Q52845695-76215E6F-940B-4C3D-9C75-B3C9BB1218A8

P2860

Polyomavirus BK neutralizing activity in human immunoglobulin preparations.

http://www.wikidata.org/entity/Q34786755

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Polyomavirus BK neutralizing activity in human immunoglobulin preparations.

@ast

Polyomavirus BK neutralizing activity in human immunoglobulin preparations.

@en

Polyomavirus BK neutralizing activity in human immunoglobulin preparations.

@nl

type

label

Polyomavirus BK neutralizing activity in human immunoglobulin preparations.

@ast

Polyomavirus BK neutralizing activity in human immunoglobulin preparations.

@en

Polyomavirus BK neutralizing activity in human immunoglobulin preparations.

@nl

prefLabel

Polyomavirus BK neutralizing activity in human immunoglobulin preparations.

@ast

Polyomavirus BK neutralizing activity in human immunoglobulin preparations.

@en

Polyomavirus BK neutralizing activity in human immunoglobulin preparations.

@nl

P1433

Q34786755-604E3E98-B9AD-4539-9729-C57EEEB7F2F3

P1476

Q34786755-A679D59C-B365-4037-A099-D73B116C6FE2

P2093

Q34786755-233551FC-E038-450E-BFA1-E48EF8C02395

Q34786755-2BE769AE-BFF3-413D-B04F-8F0803585644

Q34786755-47BE3AFC-2CAC-4280-9281-24F96FD2993D

Q34786755-739FC1F4-A96D-46C8-988C-227998178A9C

Q34786755-E241653E-2268-40A8-9E67-618F90EEC4D2

P2860

Q34786755-112E60A1-7AE7-4327-A476-B65A0DEAC7D3

Q34786755-199D0AEF-3819-4E67-A905-D9A4098C73CA

Q34786755-1AF8B8A2-FCB2-42C3-92A6-ED904E08AC91

Q34786755-2CC922EB-5FB8-4DE5-90C8-7A962B37C804

Q34786755-61656B03-FDC1-4C98-98A6-09A34A462449

Q34786755-61B973A5-7A7D-461E-AB08-12E4D352684A

Q34786755-6E8C15A5-5937-42A5-8485-4550EBDEE792

Q34786755-7143DAC7-1D55-4B6A-B394-EF5167A5A6C9

Q34786755-83A4AF57-BB86-4C4D-8F1F-CB9DDB204CDE

Q34786755-98996FD2-0FBF-45FC-828A-49721FEF8A1D

P304

Q34786755-FE70A34D-3591-46DD-85BB-E31E54E57787

P31

Q34786755-9ED437D8-AFC5-4D43-AF42-F5C28FC00679

P356

Q34786755-66ECD67D-16A2-4340-A8F1-706EB6A1A908

P433

Q34786755-21DECCC2-0010-497D-AACB-A0865E723541

P478

Q34786755-DB8D2A70-0928-46FB-95DA-3A6D0D5AF0CF

P577

Q34786755-755EF88A-B646-40D6-A86B-83C088AC6FC8

P5875

Q34786755-2A0AD544-4D3F-4585-9F53-A39357C0BED3

P698

Q34786755-0BA59436-BCF4-4F62-B7F6-F9835A2CB221

P932

Q34786755-6447CFBF-B4B9-42AB-8F87-83E4FCC93EEB

P356

TP.0B013E3181DAAAF1

P1433

Transplantation

P1476

Polyomavirus BK neutralizing activity in human immunoglobulin preparations.

@en

P2093

Kristine Schonder

http://www.w3.org/2001/XMLSchema#string

Nousha Farasati

http://www.w3.org/2001/XMLSchema#string

Parmjeet S Randhawa

http://www.w3.org/2001/XMLSchema#string

Ron Shapiro

http://www.w3.org/2001/XMLSchema#string

Yuchen Huang

http://www.w3.org/2001/XMLSchema#string

P2860

Utilization of Complement-Dependent Cytotoxicity To Measure Low Levels of Antibodies: Application to Nonstructural Protein 1 in a Model of Japanese Encephalitis Virus

BK-virus nephropathy in renal transplants-tubular necrosis, MHC-class II expression and rejection in a puzzling game.

Quantitation of viral DNA in renal allograft tissue from patients with BK virus nephropathy.

Identification of species-specific and cross-reactive epitopes in human polyomavirus capsids using monoclonal antibodies.

Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations.

BK virus nephritis after renal transplantation.

Quantitation of HLA proteins incorporated by human immunodeficiency virus type 1 and assessment of neutralizing activity of anti-HLA antibodies.

In vivo efficacy of human immunodeficiency virus neutralizing antibodies: estimates for protective titers.

Removal of a single N-linked glycan in human immunodeficiency virus type 1 gp120 results in an enhanced ability to induce neutralizing antibody responses

Structure of antibody-neutralized murine norovirus and unexpected differences from viruslike particles

P304

1462-1465

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/TP.0B013E3181DAAAF1

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

89

http://www.w3.org/2001/XMLSchema#string

P577

2010-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44693115

http://www.w3.org/2001/XMLSchema#string

P698

20568674

http://www.w3.org/2001/XMLSchema#string

P932

3075564

http://www.w3.org/2001/XMLSchema#string